Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
about
Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantationInterventions for treatment of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantationInterventions for prophylaxis of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantationAdvancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cureCurrent Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantationEmergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientStem cells in clinical practice: applications and warnings.Evaluation of an antigen-antibody "combination" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies.Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastomaDoes iron overload really matter in stem cell transplantation?Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiationSafety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.Iron overload and allogeneic hematopoietic stem-cell transplantation.Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease.A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia.Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, anInfusion of endothelial progenitor cells ameliorates liver injury in mice after haematopoietic stem cell transplantation.Predictors of the development of surgical complications among hematopoietic stem cell transplantation recipients.Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.
P2860
Q24187812-E823BC28-E09B-4347-AF83-6230863BFC8BQ24234682-F2FF408C-5647-49CD-8914-5F61E4B56B43Q24234757-8FBB9805-C4CE-46AD-B045-F2CBBD5607FEQ27027799-529D19B4-A91D-49AA-A8BC-CC4275EB1623Q30240070-F162DA21-02A3-4869-AA46-72F6082A3ABAQ34272562-A8A39C73-FACD-4364-A86D-EFA3911E1A5DQ34522746-8836916F-63FF-4FE6-9B7A-C4EA8BDCF861Q34552765-D9607F58-0A3E-44B6-9AFC-7C43B2D90CE7Q34588996-BA8C7554-B275-433D-890D-9AFC45BC697DQ35029393-9BFD414D-38E9-49A3-915B-21CB870EA487Q35859213-E780400F-2A4C-4737-B463-40BB841D563EQ35981569-7FE29280-86F4-441B-8FF8-42E9091C2B7FQ36128148-C7D42158-3399-46F4-9082-77C4B4CA1BC7Q36768621-AA080AD0-7CF3-4A72-8D1F-CEF43C1B64CDQ37637836-55942347-D07F-43E8-AD87-E45A93CAE334Q37842351-5E0EC12D-63B3-42D3-9AAB-E1F0133A7AACQ38025158-08571D60-E770-46AE-96A5-0ED9D4BB6D40Q38754283-B2E583F3-5B49-4D18-8B45-A49D4B474AD5Q40072759-AE4A2261-8278-4791-BFF4-566BAB21CBC6Q40627070-E4BF435B-697D-4A07-B942-DCB8B03C7367Q42266529-034B717A-6E98-4EDF-9121-D301C02D6B7DQ47313046-48D14F59-DAB6-41A2-9D54-3D4D46649BD4Q50523001-2041D61A-A2F6-4EA5-B1F1-33C9C3F079B0Q50989392-E006590F-5ACB-4DF2-8FB5-5A4CB93EA767Q53654186-EF4C9872-F1A4-4FEC-9601-5A39FCA813D2Q54187733-4FFDC630-9579-48DF-8D22-326C7C7C974F
P2860
Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@en
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@nl
type
label
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@en
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@nl
prefLabel
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@en
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@nl
P2093
P2860
P356
P1476
Hepatic veno-occlusive disease ...... ce, risk factors, and outcome.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2009.349
P407
P577
2009-12-14T00:00:00Z
P5875
P6179
1040637657